A randomized phase II study with alpha 2B IFN, HDEDX, CDDP and lonidamine (LND)in advanced breast cancer (ABC): preliminary data of interim analysis / R. V., I., Santangelo, M., ., .A.o.O.S.u.p.p.l.5.V.o.l.7.p.a.g.2.1.9.9.6.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - (1996), pp. 27-27.
A randomized phase II study with alpha 2B IFN, HDEDX, CDDP and lonidamine (LND)in advanced breast cancer (ABC): preliminary data of interim analysis.
SANTANGELO, MICHELE;
1996
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
